Sign in|Subscribe

ImaiAI News for Operators

Breaking

Blue Origin Targets Second New Glenn Launch for 2026 Following Pad Explosion·Amazon Prime Day 2026: How AI-Driven Predictive Logistics and Smart Groceries Are Redefining E-Commerce·Apple's MacBook Neo Dominates Mainstream Market, Capturing New Buyers·Small Businesses Unlock AI's Potential: From Accounting to Marketing·AI Policy Stalemate: Inside the Trump Administration's Battle Over Regulation·Navigating the Future: OpenAI Outlines Its Stance on AI Policy and Political Advocacy·OpenAI’s Frontier Models and Codex Now Available on AWS: A New Era for Enterprise AI·The AI IPO Era Begins: Anthropic Confidentially Files for Public Listing·Blue Origin Targets Second New Glenn Launch for 2026 Following Pad Explosion·Amazon Prime Day 2026: How AI-Driven Predictive Logistics and Smart Groceries Are Redefining E-Commerce·Apple's MacBook Neo Dominates Mainstream Market, Capturing New Buyers·Small Businesses Unlock AI's Potential: From Accounting to Marketing·AI Policy Stalemate: Inside the Trump Administration's Battle Over Regulation·Navigating the Future: OpenAI Outlines Its Stance on AI Policy and Political Advocacy·OpenAI’s Frontier Models and Codex Now Available on AWS: A New Era for Enterprise AI·The AI IPO Era Begins: Anthropic Confidentially Files for Public Listing·Blue Origin Targets Second New Glenn Launch for 2026 Following Pad Explosion·Amazon Prime Day 2026: How AI-Driven Predictive Logistics and Smart Groceries Are Redefining E-Commerce·Apple's MacBook Neo Dominates Mainstream Market, Capturing New Buyers·Small Businesses Unlock AI's Potential: From Accounting to Marketing·AI Policy Stalemate: Inside the Trump Administration's Battle Over Regulation·Navigating the Future: OpenAI Outlines Its Stance on AI Policy and Political Advocacy·OpenAI’s Frontier Models and Codex Now Available on AWS: A New Era for Enterprise AI·The AI IPO Era Begins: Anthropic Confidentially Files for Public Listing·

Tagged

Imperagen

Imperagen Secures £5M to Revolutionize Enzyme Engineering with Quantum AI

Imperagen, a pioneering biotech company, has successfully closed a £5 million seed funding round to advance its innovative approach to enzyme engineering. By integrating quantum physics with cutting-edge AI, the firm aims to overcome traditional limitations in molecular design, paving the way for more efficient and sustainable industrial processes and novel therapeutic development.